Hikal Limited, along with its subsidiaries, is engaged in the manufacturing and sale of a wide range of chemical intermediates, specialty chemicals, and active pharma ingredients. Its customer base includes pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. The company operates through two segments, namely Pharmaceuticals and Crop Protection. The Pharmaceuticals segment focuses on producing active pharmaceutical ingredients (APIs), while the Crop Protection segment specializes in manufacturing pesticides and herbicides. In addition to its manufacturing capabilities, Hikal Limited also collaborates with other companies to provide solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. Furthermore, the company offers specialty biocides and antimicrobial actives, as well as additives for various industries such as leather, paint coatings, paper, water treatment, personal care, building materials, and textiles. Established in 1988, Hikal Limited is headquartered in Navi Mumbai, India.
Hikal Limited
- 367.00 5.05(1.40%) 366.20 4.30(1.19%)
Live Hikal Limited Share Price Chart
Hikal Limited Share Performance
| Today's Low | Today's High | |
|---|---|---|
| 360.70 360.90 | 370.65 370.30 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 260.30 (13-Mar-2024) 260.65 (13-Mar-2024) | 464.75 (02-Dec-2024) 464.50 (02-Dec-2024) |
- Open
- 361.30 360.90
- Previous Close
- 361.95 361.90
- Volume
- 0.92
- Total Traded value
- 3.38 (Lakhs)
- Upper circuit
- 434.30 364.55
- Lower circuit
- 289.60 243.05
Hikal Limited Share Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 977 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 367.45 | 977.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 977 |
Hikal Limited Share Fundamentals
| Market Cap: | 45.25 Cr |
| PE Ratio (TTM): | 60.72 |
| PB Ratio: | 3.71 |
| Industry P/E: | 60.71 |
| Debt to Equity: | - |
| ROE: | 6.10 |
| EPS (TTM): | 5.96 |
| Book Value: | 91.96 |
| Face Value: | 2.00 |
Hikal Limited Stock Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 434.88 Cr | 388.05 Cr | 545.29 Cr | 540.20 Cr | 558.75 Cr |
| Profit | 12.52 Cr | 6.86 Cr | 36.07 Cr | 26.41 Cr | 24.84 Cr |
| Expense | 419.06 Cr | 379.34 Cr | 497.02 Cr | 506.92 Cr | 527.23 Cr |
| Comprehensive income | 12.38 Cr | 7.01 Cr | 34.59 Cr | 26.73 Cr | 25.14 Cr |
| EPS | 1.02 | 0.56 | 2.93 | 2.14 | 2.01 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Hikal Limited | Feb, 2001 Jan, 1995 | Pharmaceuticals Pharmaceuticals | HIKAL HIKAL |
Hikal Limited Stock Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Hikal Limited Share FAQ's
What is the range of today's stock performance for Hikal Limited?
Today's stock performance witnessed a fluctuation from a minimum of 360.70 on the NSE (National Stock Exchange) to a maximum of 370.65. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 360.90 to a high of 370.30.
What are the 52-week low and high values for Hikal Limited?
The stock's performance over the past 52 weeks reveals a low of 260.30 (occurred on 13-Mar-2024) and a high of 464.75 (achieved on 02-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 260.65 (on 13-Mar-2024), and the 52-week high is 464.50 (on 02-Dec-2024).
What was the opening and previous closing prices for Hikal Limited?
The stock's performance over the past 52 weeks reveals a low of 260.30 (occurred on 13-Mar-2024) and a high of 464.75 (achieved on 02-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 260.65 (on 13-Mar-2024), and the 52-week high is 464.50 (on 02-Dec-2024).
What is the total volume and traded value for Hikal Limited for the day?
The total volume is 1, and the total traded value is 3.38 ( Lakhs).
What are the upper and lower circuit limits for Hikal Limited?
The upper circuit limit is 434.30, and the lower circuit limit is 289.60.
What is the market cap and PE ratio for Hikal Limited?
The market cap is 45.25 Cr, and the PE ratio (TTM) is 60.71.
What is the PB ratio, industry P/E, and debt to equity ratio for Hikal Limited?
The PB ratio is 3.99, industry P/E is 60.71 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Hikal Limited?
ROE is 6.10, EPS is 5.96, book value is 91.96
What are the revenue and profit figures for the latest quarter and previous quarters for Hikal Limited?
In Sep 2023, Revenue is 4348800000.00, and Profit is 125200000.00. In Jun 2023, Revenue is 3880500000.00, and Profit is 68600000.00.
When was Hikal Limited listed, and what industry does it belong to?
The company, Hikal Limited, was listed in Feb 2001 and belongs to the Pharmaceuticals industry. Its NSE symbol is HIKAL.
What is the current shareholding pattern of the Hikal Limited?
As of latest available update, promoters hold 68.85%, the public holds 31.15%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 36
- Threads
- 195
